{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:59:25Z","timestamp":1775152765208,"version":"3.50.1"},"reference-count":43,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2005,11,25]],"date-time":"2005-11-25T00:00:00Z","timestamp":1132876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> The pathogenesis of fat redistribution syndromes (FRS) observed in the setting of highly active antiretroviral therapy (HAART) for the treatment of HIV\u20101\u2010infection remains elusive. A dysregulation of the tumour necrosis factor alpha (TNF\u2010\u03b1) system occurs in HIV\u2010infected patients with FRS.<\/jats:p><jats:p><jats:bold>Materials and methods\u2002<\/jats:bold> The study looked at both the <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> relationship between TNF\u2010\u03b1 and the degree of subcutaneous adipocyte apoptosis in 60 HIV\u20101\u2010infected patients on HAART with FRS, another 60 HIV\u20101\u2010infected patients on HAART without FRS and 60 uninfected control patients. Apoptosis was assessed by the terminal deoxynucleotidyl transferase dUTP (deoxyuridine 5\u2032\u2010triphosphate)\u2010digoxigenin Nick End Labelling (TUNEL) method. Soluble receptors of TNF\u2010\u03b1 were determined by the sandwich enzyme immunoassay technique. The <jats:italic>in vitro<\/jats:italic> viability was assessed by staining with 3\u2010(4,5\u2010dimethylthiazol\u20102\u2010yl)\u20102,5 diphenyltetrazolium bromide (MTT) and apoptosis by TUNEL.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> HIV\u20101\u2010infected patients with FRS had significantly higher degrees of subcutaneous adipocyte apoptosis than those without FRS (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b70001) and uninfected controls (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b70001). There was a statistically significant association between serum levels of soluble TNF\u2010\u03b1 receptors #1 and #2 and the degree of subcutaneous adipocyte apoptosis in patients with and without FRS (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b70001 for both receptors). <jats:italic>In vitro<\/jats:italic>, the addition of TNF\u2010\u03b1 (10\u00a0ng\u00a0mL<jats:sup>\u22121<\/jats:sup>) to an adipocyte culture embedded with indinavir, either alone or in clinically relevant combinations with stavudine (d4T) and lamivudine (3TC), significantly decreased adipocyte viability (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b70001) and increased adipocyte apoptosis (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b70001) with respect to that observed with the addition of antiretrovirals alone.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> TNF\u2010\u03b1 plays a significant role in subcutaneous adipocyte apoptosis, which occurs in the setting of FRS in HIV\u20101\u2010infected patients on highly active antiretroviral therapy.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2005.01576.x","type":"journal-article","created":{"date-parts":[[2005,11,25]],"date-time":"2005-11-25T12:57:20Z","timestamp":1132923440000},"page":"771-780","source":"Crossref","is-referenced-by-count":31,"title":["Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV\u20101\u2010infected patients: potential role in subcutaneous adipocyte apoptosis"],"prefix":"10.1111","volume":"35","author":[{"given":"P.","family":"Domingo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Sambeat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Sirvent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vendrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Matias\u2010Guiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Richart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the HIV\u2010FRS Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,11,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199911120-00008"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/323805"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.8680"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.2711"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/diab.46.12.1939","article-title":"Tumour necrosis factor\u2010\u03b1 induces apoptosis of human adipose cells","volume":"46","author":"Prins JB","year":"1997","journal-title":"Diabetes"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V95.10.3191","article-title":"Alteration of TNF\u03b1+ T cell homeostasis following potent antiretroviral therapy. Contribution to the development of HIV\u2013associated lipodystrophy syndrome","volume":"95","author":"Ledru E","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/135965350400900607","article-title":"Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression of pro\u2010inflammatory cytokines and adiponectin in vitro","volume":"9","author":"Lagathu C","year":"2004","journal-title":"Antivir Ther"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/380790"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199911120-00007"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/64.5.685"},{"key":"e_1_2_6_12_2","first-page":"3S","article-title":"Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome","volume":"36","author":"Centers for Disease Control.","year":"1987","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1128\/JCM.36.10.2964-2969.1998","article-title":"Ultrasensitive reverse transcription\u2010PCR assay for quantification of human immunodeficiency virus type 1 RNA in plasma","volume":"36","author":"Sun R","year":"1998","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/135965350300800306","article-title":"Fat distribution and metabolic abnormalities in HIV\u2010infected patients on first combination antiretroviral therapy including stavudine or zidovudine: role of physical activity as a protective factor","volume":"8","author":"Domingo P","year":"2003","journal-title":"Antivir Ther"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802068"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470773666"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/00002030-199912240-00002","article-title":"Fat distribution and metabolic changes in patients with HIV infection","volume":"13","author":"Shafrin S","year":"1999","journal-title":"AIDS"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1994.1178"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-9335(98)80110-6"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1079\/PNS2001110"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350501000202"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350400900412"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200308150-00004"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00206.2003"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00056.2003"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2005.01547.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200405010-00006"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0014-2972.2001.00940.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200307040-00011"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1086\/314572"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08094-7"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90125-7"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-002-0667-0"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.4049\/jimmunol.160.7.3194","article-title":"Differential susceptibility to activation\u2010induced apoptosis among peripheral Th1 subsets: correlation with Bcl\u20102 expression and consequences for AIDS pathogenesis","volume":"160","author":"Ledru E","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200012010-00004"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200210180-00005"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200301030-00017"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1770351"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5249.665"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050350"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.41.2.S97"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.5.1319"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922201753341988"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2005.01576.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2005.01576.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T10:51:23Z","timestamp":1697194283000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2005.01576.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,25]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1365-2362.2005.01576.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2005.01576.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,25]]}}}